Related Experiment Video
Updated: Jul 4, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Etiology-dependent prognostic impact of atrial fibrillation in implantable cardioverter-defibrillator and cardiac
Taro Temma1, Hisashi Yokoshiki2, Takeshi Mitsuhashi3
1Division of Cardiology, Sakakibara Heart Institute, Fuchu, Japan; Department of Cardiovascular Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
Insights
Atrial fibrillation (AF) significantly increases mortality risk in patients with non-ischemic cardiomyopathy (NICM) receiving cardiac devices. However, this association is less pronounced in patients with ischemic cardiomyopathy (ICM).
Area of Science:
- Cardiology
- Electrophysiology
- Heart Failure Management
Background:
- Atrial fibrillation (AF) is a common comorbidity in patients with implantable cardiac defibrillators (ICD) or cardiac resynchronization therapy (CRT).
- Existing evidence on AF's prognostic impact primarily comes from Western cohorts with ischemic cardiomyopathy (ICM), limiting generalizability to populations with higher rates of non-ischemic cardiomyopathy (NICM).
- Differences in myocardial pathology and remodeling between NICM and ICM suggest AF's prognostic significance may vary by cardiomyopathy etiology.
Purpose of the Study:
- To investigate whether the prognostic impact of AF differs between NICM and ICM in patients undergoing ICD/CRT implantation.
- To determine if AF identifies distinct risk profiles based on cardiomyopathy etiology.
Main Methods:
- Analysis of 4,623 patients from a nationwide cardiac device registry.
- Outcomes assessed included all-cause death, cardiac death, heart failure hospitalization, and ICD therapies.
- Multivariable Cox and Fine-Gray competing risk models, propensity score matching (PSM) within ICM and NICM subgroups were employed.
Main Results:
- AF was linked to higher risks of mortality, cardiac death, and heart failure hospitalization in NICM patients across all models.
- In contrast, the association between AF and mortality in ICM patients was attenuated and not statistically significant after multivariable adjustment.
- Post-PSM analysis confirmed that AF remained associated with increased mortality in NICM but not in ICM; AF's impact on ICD therapies did not differ by etiology.
Conclusions:
- The prognostic significance of AF in ICD/CRT recipients is markedly dependent on the underlying cardiomyopathy etiology.
- AF identifies a high-risk patient subgroup within NICM, while its impact is diminished in ICM.
- Etiology-specific risk stratification for AF in cardiac device patients is crucial for effective clinical management.
Background:
Atrial fibrillation (AF) is a common comorbidity in patients receiving implantable cardioverter-defibrillators (ICD) or cardiac resynchronization therapy (CRT) and is associated with increased mortality. However, most evidence comes from Western cohorts dominated by ischemic cardiomyopathy (ICM), limiting applicability to populations in which non-ICM (NICM) is more prevalent. Because NICM and ICM fundamentally differ in myocardial pathology and remodeling, the prognostic impact of AF may not be uniform across etiologies.
Objective:
This study aimed to determine whether the prognostic impact of AF differs between NICM and ICM in ICD/CRT patients.
Methods:
We analyzed data from 4,623 patients in a nationwide cardiac device registry. Outcomes were all-cause death, cardiac death, heart failure hospitalization, and ICD therapies. Multivariable Cox and Fine-Gray competing risk models were constructed using literature-based, MAGGIC-derived, and stepwise covariate selection strategies. Propensity score matching was performed within ICM and NICM subgroups.
Results:
AF was associated with higher risks of mortality, cardiac death, and heart failure hospitalization in NICM across all models. In contrast, the association between AF and mortality in ICM was attenuated and no longer statistically significant after multivariable adjustment. After propensity score matching, AF remained associated with increased mortality in NICM but not in ICM. AF impact on rates of ICD therapies did not differ between etiologies.
Conclusion:
The prognostic impact of AF among ICD/CRT recipients differs markedly by cardiomyopathy etiology. AF identifies a high-risk subgroup within NICM, whereas its effect is attenuated in ICM. Etiology-specific risk assessment should be incorporated into clinical management.
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Aortic Regurgitation I: Introduction
Cardiomyopathy V: Interprofessional Care
Rheumatic Heart Disease I: Introduction
Cardiac Catheterization I: Pre-Procedure Overview
Cardiomyopathy II: Dilated Cardiomyopathy
